RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
A new type 2 diabetes microsimulation model to estimate long-term health outcomes, costs, and cost-effectiveness
Hoerger, T. J., Hilscher, R., Neuwahl, S. J., Kaufmann, M., Shao, H., Laxy, M., Cheng, Y., Benoit, S., Chen, H., Craven, T., Yang, W., Cintina, I., Staimez, L., Zhang, P., & the Look AHEAD Research Group (2023). A new type 2 diabetes microsimulation model to estimate long-term health outcomes, costs, and cost-effectiveness. Value in Health, 26(9), 1372-1380. https://doi.org/10.1016/j.jval.2023.05.013
Highlights • Existing type 2 simulation models implement risk equations derived from UK data. This model is based on newly derived risk equations developed for the United States. This model can be used to predict remaining life-years, costs, and quality-adjusted life-years for different cohorts of type 2 patients. • Existing type 2 simulation models are limited in their extendability. This microsimulation introduces a highly modular architecture that allows for easy addition of new modules (types of diabetes, complications). A wide variety of interventions can be implemented, informing policy decision making.
